Felicia Davatolhagh is a postdoctoral researcher at the University of California, Los Angeles in Anne Churchland’s lab, where she studies how cortical circuits are altered during decision-making in a genetic mouse model of autism. She also serves as a member of the neurobiology department’s Justice, Diversity and Inclusion (JEDI) group.
Felicia Davatolhagh
Postdoctoral researcher
University of California, Los Angeles
From this contributor
Women are systematically under-cited in neuroscience. New tools can change that.
An omitted citation in a high-profile paper led us to examine our own practices and to help others adopt tools that promote citation diversity.
Women are systematically under-cited in neuroscience. New tools can change that.
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.